Literature DB >> 30747701

Selective organ ischaemia/reperfusion identifies liver as the key driver of the post-injury plasma metabolome derangements.

Nathan Clendenen1, Geoffrey R Nunns2, Ernest E Moore2,3, Eduardo Gonzalez2, Michael Chapman2, Julie A Reisz4, Erik Peltz2, Miguel Fragoso3, Travis Nemkov4, Matthew J Wither4, Angela Sauaia2, Christopher C Silliman5, Kirk Hansen4, Anirban Banerjee2, Angelo D'Alessandro4, Hunter B Moore2.   

Abstract

BACKGROUND: Understanding the molecular mechanisms in perturbation of the metabolome following ischaemia and reperfusion is critical in developing novel therapeutic strategies to prevent the sequelae of post-injury shock. While the metabolic substrates fueling these alterations have been defined, the relative contribution of specific organs to the systemic metabolic reprogramming secondary to ischaemic or haemorrhagic hypoxia remains unclear.
MATERIALS AND METHODS: A porcine model of selected organ ischaemia was employed to investigate the relative contribution of liver, kidney, spleen and small bowel ischaemia/reperfusion to the plasma metabolic phenotype, as gleaned through ultra-high performance liquid chromatography-mass spectrometry-based metabolomics.
RESULTS: Liver ischaemia/reperfusion promotes glycaemia, with increases in circulating carboxylic acid anions and purine oxidation metabolites, suggesting that this organ is the dominant contributor to the accumulation of these metabolites in response to ischaemic hypoxia. Succinate, in particular, accumulates selectively in response to the hepatic ischemia, with levels 6.5 times spleen, 8.2 times small bowel, and 6 times renal levels. Similar trends, but lower fold-change increase in comparison to baseline values, were observed upon ischaemia/reperfusion of kidney, spleen and small bowel. DISCUSSION: These observations suggest that the liver may play a critical role in mediating the accumulation of the same metabolites in response to haemorrhagic hypoxia, especially with respect to succinate, a metabolite that has been increasingly implicated in the coagulopathy and pro-inflammatory sequelae of ischaemic and haemorrhagic shock.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30747701      PMCID: PMC6774928          DOI: 10.2450/2018.0188-18

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  39 in total

1.  Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists.

Authors:  Brigitte Spath; Arne Hansen; Carsten Bokemeyer; Florian Langer
Journal:  Platelets       Date:  2011-07-07       Impact factor: 3.862

2.  Plasma First Resuscitation Reduces Lactate Acidosis, Enhances Redox Homeostasis, Amino Acid and Purine Catabolism in a Rat Model of Profound Hemorrhagic Shock.

Authors:  Angelo D'Alessandro; Hunter B Moore; Ernest E Moore; Matthew J Wither; Travis Nemkov; Alexander P Morton; Eduardo Gonzalez; Michael P Chapman; Miguel Fragoso; Anne Slaughter; Angela Sauaia; Christopher C Silliman; Kirk C Hansen; Anirban Banerjee
Journal:  Shock       Date:  2016-08       Impact factor: 3.454

3.  Hemorrhagic shock and tissue injury drive distinct plasma metabolome derangements in swine.

Authors:  Nathan Clendenen; Geoffrey R Nunns; Ernest E Moore; Julie A Reisz; Eduardo Gonzalez; Erik Peltz; Christopher C Silliman; Miguel Fragoso; Travis Nemkov; Matthew J Wither; Kirk Hansen; Anirban Banerjee; Hunter B Moore; Angelo DʼAlessandro
Journal:  J Trauma Acute Care Surg       Date:  2017-10       Impact factor: 3.313

4.  Pathologic metabolism: an exploratory study of the plasma metabolome of critical injury.

Authors:  Erik D Peltz; Angelo D'Alessandro; Ernest E Moore; Theresa Chin; Christopher C Silliman; Angela Sauaia; Kirk C Hansen; Anirban Banerjee
Journal:  J Trauma Acute Care Surg       Date:  2015-04       Impact factor: 3.313

5.  Shock releases bile acid inducing platelet inhibition and fibrinolysis.

Authors:  Gregory Wiener; Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Scott Diamond; Shu Zhu; Angelo D'Alessandro; Anirban Banerjee
Journal:  J Surg Res       Date:  2015-01-29       Impact factor: 2.192

6.  Adenosine in hemorrhagic shock: possible role in attenuating sympathetic activation.

Authors:  C S Tung; K M Chu; C J Tseng; T H Yin
Journal:  Life Sci       Date:  1987-09-14       Impact factor: 5.037

7.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α.

Authors:  G M Tannahill; A M Curtis; J Adamik; E M Palsson-McDermott; A F McGettrick; G Goel; C Frezza; N J Bernard; B Kelly; N H Foley; L Zheng; A Gardet; Z Tong; S S Jany; S C Corr; M Haneklaus; B E Caffrey; K Pierce; S Walmsley; F C Beasley; E Cummins; V Nizet; M Whyte; C T Taylor; H Lin; S L Masters; E Gottlieb; V P Kelly; C Clish; P E Auron; R J Xavier; L A J O'Neill
Journal:  Nature       Date:  2013-03-24       Impact factor: 49.962

8.  EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

Authors:  Benjamin A Olenchock; Javid Moslehi; Alan H Baik; Shawn M Davidson; Jeremy Williams; William J Gibson; Abhishek A Chakraborty; Kerry A Pierce; Christine M Miller; Eric A Hanse; Ameeta Kelekar; Lucas B Sullivan; Amy J Wagers; Clary B Clish; Matthew G Vander Heiden; William G Kaelin
Journal:  Cell       Date:  2016-02-25       Impact factor: 41.582

9.  Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.

Authors:  Edward T Chouchani; Victoria R Pell; Edoardo Gaude; Dunja Aksentijević; Stephanie Y Sundier; Ellen L Robb; Angela Logan; Sergiy M Nadtochiy; Emily N J Ord; Anthony C Smith; Filmon Eyassu; Rachel Shirley; Chou-Hui Hu; Anna J Dare; Andrew M James; Sebastian Rogatti; Richard C Hartley; Simon Eaton; Ana S H Costa; Paul S Brookes; Sean M Davidson; Michael R Duchen; Kourosh Saeb-Parsy; Michael J Shattock; Alan J Robinson; Lorraine M Work; Christian Frezza; Thomas Krieg; Michael P Murphy
Journal:  Nature       Date:  2014-11-05       Impact factor: 49.962

10.  Changes in metabolic profiles during acute kidney injury and recovery following ischemia/reperfusion.

Authors:  Qingqing Wei; Xiao Xiao; Paul Fogle; Zheng Dong
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more
  3 in total

1.  COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status.

Authors:  Tiffany Thomas; Davide Stefanoni; Julie A Reisz; Travis Nemkov; Lorenzo Bertolone; Richard O Francis; Krystalyn E Hudson; James C Zimring; Kirk C Hansen; Eldad A Hod; Steven L Spitalnik; Angelo D'Alessandro
Journal:  JCI Insight       Date:  2020-07-23

2.  Plasma levels of carboxylic acids are markers of early kidney dysfunction in young people with type 1 diabetes.

Authors:  Timothy Vigers; Carissa Vinovskis; Lu-Ping Li; Pottumarthi Prasad; Hiddo Heerspink; Angelo D'Alessandro; Julie A Reisz; Federica Piani; David Z Cherney; Daniel H van Raalte; Kristen J Nadeau; Meda E Pavkov; Robert G Nelson; Laura Pyle; Petter Bjornstad
Journal:  Pediatr Nephrol       Date:  2022-05-04       Impact factor: 3.714

Review 3.  Preclinical models versus clinical renal ischemia reperfusion injury: A systematic review based on metabolic signatures.

Authors:  Lente J S Lerink; Michèle J C de Kok; John F Mulvey; Sylvia E Le Dévédec; Alexander A Markovski; Rob C I Wüst; Ian P J Alwayn; Rutger J Ploeg; Alexander F M Schaapherder; Jaap A Bakker; Jan H N Lindeman
Journal:  Am J Transplant       Date:  2021-11-01       Impact factor: 9.369

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.